Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Eterna Therapeutics logo — Laser Focus with Relentless Execution

Eterna Therapeutics

Laser Focus with Relentless Execution

Founded 1994 United States Cambridge, United States 5 employees Post-IPO Debt Total: $49.08M Biotechnology, Health Care +2

General Information

Company Name Eterna Therapeutics
Founded Year 1994
Location United States Cambridge, United States
Employees 5
Industries Biotechnology, Health Care, Health and Wellness +1
Funding Stage Post-IPO Debt
Social

BounceWatch is an independent company data service, not affiliated with Eterna Therapeutics. To contact Eterna Therapeutics, visit eternatx.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Eterna Therapeutics compare?

A PDF of Eterna Therapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Eterna Therapeutics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Eterna Therapeutics

Eterna Therapeutics, established in 1984, is a biotechnology and pharmaceutical company headquartered in the United States. The company is focused on developing transformative medicines to address various forms of cancer and other diseases with high unmet medical needs. Utilizing breakthrough mRNA cell engineering technologies, Eterna Therapeutics aims to repair cellular dysfunction and provide treatment for a range of therapeutic indications. Through strategic partnerships, the company is advancing innovative nucleic acid and cell therapies to significantly improve the health outcomes of patients. With a commitment to ensuring access to effective treatments for serious illnesses, Eterna Therapeutics is dedicated to creating a world where patients and their families can benefit from life-changing therapies. The company recently secured a $9.20M post-IPO debt investment on 14 December 2023.

Business keywords: mRNA cell engineering, nucleic acid therapies, cell therapies, immune system restoration, cancer treatment, therapeutic indications, human derived cytokines, gene editing, non-viral nucleic acid delivery, cellular reprogramming

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Post IPO Debt $9.20M -
14 Dec 2023
Post IPO Debt $8.70M -
18 Jul 2023
Post IPO Equity $10.00M 1
Lincoln Park Capital Fund
Lincoln Park Capital Fund
11 Apr 2023
Post IPO Equity $21.18M -
06 Nov 2018

Eterna Therapeutics Alternatives & Competitors

View All Alternatives
Eterna Therapeutics vs
Turn Biotechnologies
Turn Biotechnologies United States

Turn Bio is developing longevity solutions to combat diseases of aging by restoring youthful perform...

15 employees
Biotechnology, Pharmaceutical
Eterna Therapeutics vs
Gennao Bio
Gennao Bio United States

A genetic medicines company developing first-in-class, targeted nucleic acid therapeutics

Series A
5 employees
Biotechnology, Health Care
Eterna Therapeutics vs
Immunaeon
Immunaeon United States

Connecting Today's Science to Tomorrow's Cures

5 employees
Biopharma, Biotechnology
View all alternatives

FAQ About Eterna Therapeutics

Laser Focus with Relentless Execution
Eterna Therapeutics was founded in 1994.
Eterna Therapeutics is headquartered in Cambridge, United States.
Eterna Therapeutics operates in Biotechnology, Health Care, Health and Wellness and Pharmaceutical. Its work centres on mRNA cell engineering, nucleic acid therapies, cell therapies and immune system restoration.
Eterna Therapeutics has approximately 5 employees.
Eterna Therapeutics has completed 4 funding rounds, raising a total of $49.08M. The latest funding stage is Post-IPO Debt.
Top alternatives and competitors to Eterna Therapeutics include Turn Biotechnologies, Gennao Bio, Immunaeon, Anjarium Biosciences AG, Nuntius Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Eterna Therapeutics and Turn Biotechnologies are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Eterna Therapeutics, https://bouncewatch.com/company/eterna-therapeutics, updated 13 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes